Announcements Trials
Browse Landscape

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Genitourinary 3Endocrine 3NET 2Lymphoid 2Gastrointestinal 2CNS 2Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Gynecologic 1Breast 1

Conditions

Neuroendocrine Tumors 2Neurodegenerative Diseases 1Carcinoma, Neuroendocrine 1Brain Neoplasms 1

Interventions

Surveys and Questionnaires 8Blood Specimen Collection 7lutetium Lu 177 dotatate 6Surgical Procedures, Operative 6Magnetic Resonance Spectroscopy 6Adrenalectomy 5Observation 4Transurethral Resection of Prostate 3Thyroidectomy 3Positron-Emission Tomography 3Lymph Node Excision 3Data Collection 3telotristat ethyl 2surufatinib 2gallium Ga 68 dotatate 2Somatostatin 2Radionuclide Imaging 2Radiofrequency Ablation 2Everolimus 2Drug Therapy 2Biopsy 2somapacitan 1methyl hydroxyethyl cellulose 1lanreotide 1fluorodopa F 18 1exemestane 1delta 24-sterol reductase 1copper dotatate CU-64 1Whole Body Imaging 1Walking 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Positron-Emission Tomography × Endocrine × Clear all
NCT04069299 2026-03-31

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

H. Lee Moffitt Cancer Center and Research Institute

Completed
30 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT06448208 2026-03-09

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Memorial Sloan Kettering Cancer Center

Active not recruiting
11 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT06211803 2024-01-18

JPETClinic

Jagiellonian University

Completed
10 enrolled
CNSEndocrineNET

Brain Neoplasms, Neuroendocrine Tumors, Neurodegenerative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡